European Commission Approves Celltrion Healthcare's Vegzelma™ (CT-P16, biosimilar bevacizumab) for the Treatment of Multiple Types of Cancer
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com